Trial Profile
Phase III Randomized Adjuvant Study of Tamoxifen Alone Versus Sequential Tamoxifen and Anastrozole in Hormone-Responsive Postmenopausal Breast Cancer Patients.
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 14 Sep 2015
Price :
$35
*
At a glance
- Drugs Anastrozole (Primary) ; Tamoxifen
- Indications Early breast cancer
- Focus Adverse reactions; Therapeutic Use
- 08 Jun 2009 New trial record.